The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The impact of natural products upon modern drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
A Predictably Selective Aliphatic C–H Oxidation Reaction for Complex Molecule Synthesis
Chen, M. S., & White, M. C. (2007) · Science · doi:10.1126/science.1148597 · Cited by 1,291
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Drug discovery from natural sources
Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Ligand efficiency indices as guideposts for drug discovery
Abad-Zapatero, C., & Metz, J. T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03386-6 · Cited by 527
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
The druggable genome: an update
Russ, A. P., & Lampel, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03666-4 · Cited by 424
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
Rhodium Boryl Complexes in the Catalytic, Terminal Functionalization of Alkanes
Hartwig, J. F., Cook, K. S., Hapke, M., Incarvito, C. D., Fan, Y., Webster, C. E., & Hall, M. B. (2005) · Journal of the American Chemical Society · doi:10.1021/ja045090c · Cited by 348
Natural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
Self-citationTime-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
Raub, T. J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500871 · Cited by 221
Chris Lipinski discusses life and chemistry after the Rule of Five
Owens, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02556-4 · Cited by 171
Fragment screening: an introduction
Leach, A. R., Hann, M. M., Burrows, J. N., & Griffen, E. J. (2006) · Molecular BioSystems · doi:10.1039/b610069b · Cited by 163
Fragment-based lead discovery: a chemical update
Erlanson, D. A. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.007 · Cited by 149
Kennedy, J. (2007) · Natural Product Reports · doi:10.1039/b707678a · Cited by 140
Properties and Architecture of Drugs and Natural Products Revisited
Grabowski, K., & Schneider, G. (2007) · Current Chemical Biology · doi:10.2174/2212796810701010115 · Cited by 132
Total Synthesis of Spiruchostatin A, a Potent Histone Deacetylase Inhibitor
Yurek‐George, A., Habens, F., Brimmell, M., Packham, G., & Ganesan, A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039258q · Cited by 102
Self-citationNatural products as a hunting ground for combinatorial chemistry
Ganesan, A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.09.002 · Cited by 94
Self-citation2007 FDA drug approvals: a year of flux
Hughes, B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2514 · Cited by 92
Yurek‐George, A., Cecil, A., Mo, A. H. K., Wen, S., Rogers, H., Habens, F., Maeda, S., Yoshida, M., Packham, G., & Ganesan, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703800 · Cited by 85
Self-citationExploiting Chemical Diversity for Drug Discovery
(2006) · Royal Society of Chemistry eBooks · doi:10.1039/9781847552556 · Cited by 65
Wen, S., Carey, K. L., Nakao, Y., Fusetani, N., Packham, G., & Ganesan, A. (2007) · Organic Letters · doi:10.1021/ol070046y · Cited by 59
Self-citationNatural products: chemical instruments to apprehend biological symphony
Pucheault, M. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b713022h · Cited by 42
Combinatorial Synthesis of Natural Product-Based Libraries
(2006) · CRC Press eBooks · doi:10.1201/9781420009279 · Cited by 35
The art and practice of structure-based drug design: A molecular modeling perspective
(1996) · doi:10.1002/(sici)1098-1128(199601)16:1<3::aid-med1>3.0.co;2-6
Cited by
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Medicinal plants: Past history and future perspective
Jamshidi-Kia, F., Lorigooini, Z., & Amini-Khoei, H. (2018) · Journal of Herbmed Pharmacology · doi:10.15171/jhp.2018.01 · Cited by 925
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Metadata
- Authors
- Ganesan, A.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 12
- Issue
- 3
- Pages
- 306-317
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W2039965018
- Cited by
- 646
- References
- 36
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.